Once again, daily aspirin is shown to be deadly rather than beneficial

September 16, 2018- by Steven E. Greer, MD

The Healthcare Channel has been pounding the table for many years pushing back against the drug industry that has been promoting daily aspirin as a wonder drug. The evidence has always been lacking to warrant daily aspirin as a way to reduce the chance of myocardial infarction. Meanwhile, the evidence that aspirin increases deadly GI and brain bleeding is overwhelming.

Now, several new large studies in the NEJM demonstrate, once again, that daily aspiring is deadly, due to bleeding, and does not reduce MI in primary prevention.

Daily aspirin once again proves to be of no use and also deadly

Brigham and Women’s Hospital engages in bizarre PR campaign for daily aspirin

 

This entry was posted in - NEJM, - Pharma, Cardiac surgery, Cardiology, Gastroenterology and liver, Geriatrics, Internal Medicine, Neurology, Neurosurgery, Oncology, Vascular Surgery. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *